Skip to main content
Douglas Graham, MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

DouglasGrahamMDPhD

Pediatric Hematology & Oncology Atlanta, GA

Pediatric Hematologic Oncology

Chief, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Emory University; William G. Woods, MD, Chair; Division Chief, Pediatric Hematology/Oncology/BMT

Dr. Graham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Graham's full profile

Already have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Hematology/Oncology, 1999 - 2003
  • University of Colorado
    University of ColoradoResidency, Pediatrics, 1996 - 1999
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1996
  • University of North Carolina at Chapel Hill
    University of North Carolina at Chapel HillPh.D., 1990 - 1994
  • Wake Forest University
    Wake Forest UniversityB.S., Biology, With honors, 1983 - 1987

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2015 - 2025
  • CO State Medical License
    CO State Medical License 1998 - 2017
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Technology Transfer Office Bioscience Discovery Award University of Colorado, 2013
  • Research Scholar Award American Cancer Society, 2009
  • Damon Runyon-Novartis Clinical Investigator Award 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of a dual Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia  
    Lee Sherick A, Zhang W, Menachof K, Hill A, Rinella S, Stashko M, Jordan C, Wei Q, Liu J, Zhang D, DeRyckere D, Wang X, Frye S, Earp HS, and DK Graham, Oncotarget, 1/1/2015
  • Epigenetic reprogramming to reverse chemoresistance in childhood acute lymphoblastic leukemia  
    Newton TP, Cummings CT, Graham DK, and KM Bernt, International Journal of Hematologic Oncology, 1/1/2014
  • The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer  
    Graham DK, DeRyckere D, Davies KD, and HS Earp, Nat Rev Cancer, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Development of a novel small molecule MER tyrosine kinase inhibitor with therapeutic activity in cell culture and mouse models of acute lymphoblastic leukemia
    DeRyckere D, Hill AA, Wang X, Zhang W, Stashko MA, Sather S, Cummings C, Kireev D, Janzen WP, Frye SV, Earp HS, and DK Graham, American Association of Cancer Researchers Annual Meeting, San Diego, CA, 1/1/2014
  • Inhibition of Mer tyrosine kinase with a novel small molecule inhibitor is efficacious in pre-clinical models of non-small cell lung cancer
    Cummings CT, Davies KD, Carrico J, DeRyckere D, Zhang W, Wang X, Frye S, Earp HS, and DK Graham, American Association of Cancer Researchers Annual Meeting, San Diego, CA, 1/1/2014
  • A small molecule Mer tyrosine kinase inhibitor (UNC MerTKi) effectively inhibits growth of murine melanoma
    Earp HS, Darr D, Zimmermann A, Clark K, Sharpless NE, Bergmeier W, Zhang W, Wang X, DeRyckere D, Frye S, and DK Graham, American Association of Cancer Researchers Annual Meeting, San Diego, CA, 1/1/2014
  • Join now to see all

Lectures

  • Targeted inhibition of MerTK as novel cancer therapy 
    Madison, WI - 1/18/2015
  • Transitioning MerTK Inhibitors Into the Clinic as Novel Cancer Therapy 
    1/15/2015
  • Development of dual Mer/FLT3 inhibitors 
    Boulder, CO - 1/12/2015
  • Join now to see all

Other

  • The MERTK signaling pathway in cancer 
    Hill AA, Carrico JA, DeRyckere D, and DK Graham, eLS. John Wiley & Sons, Ltd
    1/1/2015

Professional Memberships

Hospital Affiliations